as a histidine-tagged enzyme. The specific activity of the purified fusion enzyme is 80 nmol of 5-hydroxytryptophan/ min/mg. Multifunctional regulatory 14-3-3 proteins were purified from fresh bovine brain. Phosphorylation and 14-3-3 proteins play important roles in the regulation of TPH activity. We have found that phosphorylation of TPH by cAMP-dependent protein kinase increased the activity of the hydroxylase by 25-30% and that 14-3-3 proteins increased the hydroxylase activity of phosphorylated TPH by ϳ45%. Under these conditions, the 14-3-3 proteins were not phosphorylated, and unphosphorylated TPH was not activated by 14-3-3 proteins. Surface plasmon resonance analysis demonstrated that 14-3-3 proteins bind to phosphorylated TPH with an affinity constant (K a ) of 4.5 ؋ 10 7 M
. Binding studies using affinity chromatography also showed that 14-3-3 proteins interact with phosphorylated TPH. The dephosphorylation of TPH by protein phosphatase-1 was inhibited by 14-3-3 proteins. Our results demonstrate that 14-3-3 proteins form a complex with phosphorylated brain TPH, thereby increasing its enzymatic activity and inhibiting its dephosphorylation.
Tryptophan hydroxylase (TPH 1 ; EC 1.14.16.4), a member of the family of pterin-dependent aromatic amino-acid hydroxylases, catalyzes the conversion of L-tryptophan to 5-hydroxy-Ltryptophan (1, 2) . This reaction is the initial and rate-limiting step in the synthesis of the neurotransmitter serotonin (3) . In light of the widespread involvement of serotonin in brain function and psychiatric illnesses (4 -6) , an in-depth understanding of TPH regulation would provide information on how this important brain enzyme modulates physiological and pathological processes mediated by serotonin. Because of its low abundance and extreme instability, biochemical characterization of TPH has been hampered (7, 8) . TPH isolated from different sources also exhibits distinct properties (8, 9) . Rabbit brain TPH expressed in Escherichia coli is largely insoluble (10) and extremely unstable (11) . Moreover, little is known about its regulatory properties in vitro, except that it is sensitive to substrate inhibition (12) . The 14-3-3 proteins are acidic, ubiquitous, and highly conserved proteins that were first discovered in the brain (reviewed in Ref. 13 ). The first function assigned to 14-3-3 proteins was that of activators of the neuronal enzymes tyrosine and tryptophan hydroxylases (14) . Subsequently, the 14-3-3 family of proteins was shown to bind to a variety of proteins involved in signal transduction and cell cycle regulation (15) (16) (17) (18) (19) (20) (21) (22) (23) . Although the exact function of 14-3-3 is not known, numerous biological activities have been attributed to it. Given the large and diverse numbers of proteins that can apparently bind 14-3-3, it is important to determine the nature of these interactions. Several observations suggest that 14-3-3 interactions involve binding to phosphoserine. Activation of tyrosine hydroxylase by 14-3-3 requires prior phosphorylation of the hydroxylase with the serine/threonine kinase calmodulin kinase II (24) . Phosphatase treatment of Raf-1 and Bcr inhibits their association with 14-3-3 in vitro (25) , and 14-3-3 binding to Raf-1 blocks the ability of phosphatases to inhibit Raf-1 activity (26) . Furthermore, 14-3-3 may bind to phosphoserine in a sequence-specific manner (57) .
Several reports have described the bacterial expression of TPHs from different species (9, 10, 27) . However, the bacterially expressed enzymes have proven to be mostly insoluble. By use of a fusion expression system, soluble TPH species have been expressed in E. coli (8, 28) . It has been reported for rat phenylalanine and tyrosine hydroxylases that the baculovirus expression system yields recombinant enzymes with properties that are more similar to those of the native enzymes than these hydroxylases expressed in E. coli (29, 30) . Based on these observations, we decided that the baculovirus-insect cell expression system might provide an approach to obtaining soluble active TPH. This study describes the high level expression of rabbit brain histidine-tagged TPH in insect cells. Using unphosphorylated and phosphorylated TPHs, we have studied the stability and binding of TPH to 14-3-3 proteins as well as the effect of this interaction on activation and dephosphorylation of TPH.
EXPERIMENTAL PROCEDURES
Materials-The BAC-TO-BAC baculovirus expression vector kit, DH10BAC competent cells, CellFectin reagent, Ni 2ϩ -NTA resin, and recombinant TEV protease were obtained from Life Technologies, Inc. The bovine brain catalytic subunit of PKA was purchased from Sigma, and the PKA inhibitor isoquinolinesulfonamide was from Research Biochemicals Inc. The Mark 12 molecular mass marker was from Novex. All other reagents were of analytical grade.
Generation of Recombinant Baculovirus for Expression of Rabbit
Brain TPH-The BAC-TO-BAC baculovirus expression system was used for expression of rabbit brain TPH. The TPH coding sequence (1.58 kilobases) was amplified from plasmid pjptRABB6016 (10) by polymerase chain reaction using the primers 5Ј-CGC TCA TGA TTG AAG ATA-ATA AAG AG-3Ј (N terminus) and 5Ј-TGC TCT AGA TCA GAC ACT-CAG CTG CCT-3Ј (C terminus) and was cloned into the pUC18 vector. After confirmation by DNA sequencing, the TPH sequence was digested * The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
with BspHI (leaving a compatible end with NcoI) and XbaI and cloned into the NcoI and XbaI sites of the donor plasmid pFASTBACHT a . After site-specific transposition of the recombinant plasmid in E. coli DH10BAC competent cells, colonies containing recombinant bacmids were identified by disruption of the lacZ␣ gene. The recombinant bacmid DNA was isolated and used for transfection of Sf21 insect cells using CellFectin liposome. After incubation at 27°C for 72 h, the virus was amplified to a titer of 2 ϫ 10 7 plaque-forming units/ml. Expression of rabbit brain TPH was then conducted by infecting Sf21 cells at a multiplicity of infection of 1.0 for 72 h in the presence of 0.1 mM FeSO 4 . Cells were harvested by centrifugation, washed with 0.85% NaCl, and stored at Ϫ80°C.
Purification of Histidine-tagged TPH Produced in the pFAST-BACHT a Expression Vector from the Infected Sf21 Cell Line-All purification steps were carried out in a cold room. The cell pellets (ϳ2.5 g) were suspended in 15 ml of Buffer A (50 mM Tris-Cl, pH 8.5, containing 100 mM KCl, 10% glycerol, 20 mM imidazole, 0. Fractions were pooled based on TPH activity, and the purity of the active fractions of TPH was determined by 8 -16% SDS-PAGE and Coomassie Blue staining. The six-histidine tag was removed using recombinant TEV protease according to the manufacturer's protocol.
Purification of 14-3-3 Proteins from Bovine Brain-14-3-3 proteins were purified according to a previously described protocol (31) with some modifications. Fresh bovine calf brain (200 g) was homogenized in 100 ml of Buffer D (40 mM NaHepes, pH 7.5, containing 150 mM NaCl, 5 mM EGTA, 1 mM DTT, and 0.2 mM 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride). The homogenate was centrifuged at 151,000 ϫ g for 1.5 h. The 70-ml supernatant was concentrated to 10 ml by ultrafiltration, loaded onto a Sephacryl S-300 column (2 ϫ 80 cm) equilibrated with Buffer E (20 mM Tris-Cl, pH 7.5, containing 100 mM NaCl, 1 mM EGTA, and 0.5 mM DTT), and eluted at a flow rate of 1 ml/min. Pooled fractions containing 14-3-3 proteins were loaded onto a DEAE-Sephacel column (1.5 ϫ 45 cm) previously equilibrated with Buffer E. After washing with 2 volumes of Buffer E, a linear gradient of 0.2-0.4 M NaCl in Buffer E was run at a flow rate of 1 ml/min. Pooled fractions containing 14-3-3 proteins were concentrated to 2 ml, loaded onto a Sephacryl S-200 column (1 ϫ 100 cm) equilibrated with Buffer E, and eluted at a flow rate of 0.5 ml/min. Pooled 14-3-3 proteins from the Sephacryl S-200 column were fractionated on a Mono Q HR 5/5 column. The gradient used was 0 -1 M NaCl in 20 mM Tris-Cl, pH 7.5, at a flow rate of 0.5 ml/min, and 0.5-ml fractions were collected. SDS-PAGE showed that the 14-3-3 proteins were ϳ95% pure.
TPH Enzymatic Assay in the Presence and Absence of 14-3-3 Proteins-All experiments on the effects of 14-3-3 on the catalytic activity of TPH were carried out with histidine-tagged enzyme. TPH activity was measured by the fluorometric determination of the product 5-HTP as described (32) with a few modifications. The assay mixture contained 50 mM Tris-Cl, pH7.5, 125 M L-tryptophan, 1 mM DTT, 1 mM NADH, 0.39 unit/ml dihydropteridine reductase, 10 mM D-glucose 6-phosphate, 5 milliunits/ml D-glucose-6-phosphate dehydrogenase, 0.2 mg/ml catalase, and 0.25 mM cofactor ((6R)-5,6,7,8-tetrahydrobiopterin) in a final volume of 0.1 ml. The reaction was initiated by the addition of TPH, incubated at 37°C for 15 min, terminated with 0.1 ml of 10.5 M HCl and 1.3 M HClO 4 , chilled on ice for 5 min, and finally centrifuged at room temperature for 5 min. Upon excitation at 295 nm, the fluorescence of the supernatant at 538 nm was measured on an LS-3B fluorescence spectrophotometer (Perkin-Elmer) using 5-HTP as the standard. One unit of TPH activity is defined as the amount of TPH that catalyzes the formation of 1 nmol of 5-HTP/15 min at 37°C.
Phosphorylation of TPH-Phosphorylation of TPH (0.7 g) was carried out in a 50-l reaction mixture containing 50 mM Tris-Cl, pH 7.5, 50 mM KCl, 10 mM MgCl 2 , 1 mM DTT, 0.1 mM ATP, and 1 g of TPH. The reaction was initiated by the addition of 1 g of PKA catalytic subunit and incubated at 30°C for 30 min. The phosphorylation reaction was quenched by the addition of a 1 mM concentration of the PKA inhibitor isoquinolinesulfonamide.
Dephosphorylation of TPH-TPH (1 g) was phosphorylated with PKA and [␥-32 P]ATP (3000 Ci/mmol) in the presence and absence of 14-3-3 proteins (10 g) at 30°C for 30 min in 0.1 ml. The phosphorylation reaction was quenched with a 1 mM concentration of the PKA inhibitor isoquinolinesulfonamide. The dephosphorylation reaction was carried out at 37°C by the addition of 50 ng of protein phosphatase-1 catalytic subunit (Promega, Madison, WI). The reaction was quenched at different time points by the addition of 12.5% trichloroacetic acid using bovine serum albumin as a carrier protein for precipitation. After thorough washing, the precipitate was dissolved in 0.1 N NaOH, and the radioactivity of the precipitated protein was measured.
Association of 14-3-3 Proteins with TPH-TPH was dialyzed in Buffer F (50 mM Tris-Cl, pH 7.5, containing 200 mM KCl, 5% glycerol, 0.1 mM FeSO 4 , 0.05 mM L-tryptophan, and 0.05% Tween 20). Unphosphorylated and phosphorylated TPHs (3.5 g) were immobilized on Ni 2ϩ -NTA resins, and then 2.2 g of 14-3-3 proteins were added. After washing, the whole complex was eluted with 50 mM Tris-Cl, pH 8.5, containing 150 mM imidazole, and bound proteins were detected by SDS-PAGE.
Surface Plasmon Resonance (SPR) Studies of 14-3-3 and Phosphorylated Tryptophan Hydroxylase-The interaction of phosphorylated TPH with immobilized 14-3-3 was monitored by surface plasmon resonance detection using BIAcore 2000 (Biocore, Inc., Uppsala, Sweden). The basic principles and detection methods have been reviewed previously (33, 34) . All binding experiments were performed with recombinant TEV protease-digested TPH at 25°C. The buffer used was 50 mM Tris-Cl, pH 7.8, containing 100 mM KCl, 1 mM MgCl 2 , 1 mM DTT, and 0.05% surfactant P-20 (Pharmacia). The 14-3-3 proteins (50 -100 g/ml) were coupled to the carboxymethylated dextran matrix on a CM5 sensor chip (Biocore, Inc.) using an amine coupling kit following the manufacturer's directions. The data were analyzed using the software BIAevaluation 2.1 (Pharmacia). The concentration of the complex can be measured directly as the steady-state resonance (R eq ) when performing equilibrium binding experiments with BIAcore (35, 36) , whereas the concentration of free analyte (C) can be considered equal to the bulk analyte concentration since it is continuously replenished during sample injection. The concentration of free ligand on the surface of the sensor chip is then derived from the concentration of the complex (R eq ) and the total binding capacity of the surface (R max ) as follows: K a ϭ R eq /C(R max Ϫ R eq ). Rearranging, we obtain the following: R eq /C ϭ K a R max Ϫ K a R eq . Thus, the association constant (K a ) was determined from the plot of R eq /C versus R eq at different analyte concentrations by Scatchard analysis, after correction for nonspecific binding. The equilibrium dissociation constant (K D ) was also determined from the rate of dissociation/rate of association by biomolecular interaction analysis simulation.
Other Methods-Phosphate incorporation mediated by PKA was determined by published procedures (37) . Protein concentrations were determined by the BCA method (Pierce). Data were analyzed using KaleidaGraph Ultrafit computer software.
RESULTS

Expression and Purification of Rabbit
Brain TPH-To achieve high level expression and to permit affinity purification of active TPH, a His 6 -tagged fusion protein expression and purification system was used by means of site-specific transposition of an expression cassette into a baculovirus shuttle vector (bacmid) propagated in E. coli (38) as described under "Experimental Procedures." The fusion enzyme contains a sixhistidine affinity tag, a 7-amino acid spacer arm, and the TEV protease recognition site for cleavage of the six-histidine tag from the protein. The infection of insect cells with recombinant baculovirus was optimized using different multiplicities of infection and also by variation of the time course of infection at a constant multiplicity of infection. Assays indicated that a multiplicity of infection of 1.0 at 72-84 h post-infection in a 27°C shaker gave a high expression of soluble active TPH. The specific activity of TPH in the crude extract was 4 nmol/min/mg of protein.
Because of the inherent instability of TPH (39), 0.1 mM FeSO 4 was included in the lysis buffer to stabilize the enzyme. Fig. 1 shows the expressed His 6 -tagged TPH (lane 3) and the purified TPH after TEV protease digestion (lane 4); the molecular mass of the fusion enzyme was ϳ54 kDa and ϳ2.5 kDa (23 amino acids were removed) after recombinant TEV protease digestion. The activities of the purified fusion enzyme and the digested TPH were the same (80 nmol of 5-HTP/min/mg of enzyme). This value is comparable to that found for human TPH fused with maltose-binding protein (9) . The yield was 30%, and the purification was ϳ40-fold.
The 14-3-3 proteins were prepared from bovine brain as described under "Experimental Procedures." They had molecular characteristics very similar to those described (40, 41) . The 14-3-3 proteins isolated from tissues are heterogeneous, containing two or more molecular species (42) . Consistent with this observation, our 14-3-3 preparation was separated by SDS-PAGE into two polypeptides with apparent molecular masses of 30 and 27 kDa in a respective ratio of 4:1.
Effect of 14-3-3 Concentration on TPH Activation-TPH was phosphorylated by PKA using [␥-32 P]ATP. A maximum of 0.4 mol of phosphate/mol of TPH subunit was incorporated after a 30-min incubation at 30°C. Half-maximum phosphorylation took ϳ10 min. The rate and extent of TPH phosphorylation by PKA were not affected by 14-3-3 proteins. The value of 0.4 mol of phosphate/mol of TPH is twice the value obtained by another group (24) . This difference could be due to a different source of TPH used in the two studies.
In an initial experiment, the ability of different concentrations of 14-3-3 to activate phosphorylated TPH was studied. As shown in Fig. 2 , under the experimental conditions used, 14-3-3 activated phosphorylated TPH ϳ30%, with maximum stimulation observed at ϳ15 g/ml 14-3-3 proteins (half-maximum stimulation at 2.5 g/ml). There was no effect of 14-3-3 on the activity of unphosphorylated TPH, as can be seen in the controls in which PKA was replaced by bovine serum albumin. The stimulation of our recombinant TPH preparation by 14-3-3 proteins is somewhat less than the 70% stimulation observed with partially purified TPH from rat brainstem (43) .
Time Course of Activation of Phosphorylated TPH by 14-3-3-The formation of 5-HTP by TPH under different conditions is shown in Fig. 3 . TPH was phosphorylated as described under "Experimental Procedures." Unphosphorylated TPH in the presence of bovine serum albumin was treated in the same way as phosphorylated TPH, but without added kinase. During the first 5 min of incubation, 14-3-3 stimulated the activity of phosphorylated TPH by ϳ45% (Fig. 3, छ versus Ⅺ) . Under the conditions of this experiment, even in the absence of 14-3-3, incubation of TPH under phosphorylation conditions caused a small but reproducible increase in hydroxylase activity (Fig. 3, E versus छ). The combination of phosphorylation and 14-3-3 proteins resulted in a 70% stimulation of TPH activity (Fig. 3,  E versus Ⅺ) . The results also indicate that during the subsequent 5-min incubation (i.e. in the 5-10-min period), there was no further increase in TPH activity due to either phosphorylation or 14-3-3 proteins. In the experiment shown in Fig. 3 , 14-3-3 proteins were present during the phosphorylation reaction. A nearly identical result was obtained when 14-3-3 proteins were added after the phosphorylation reaction.
To determine whether 14-3-3 proteins affect the stability of phosphorylated TPH, we first phosphorylated the enzyme and then quenched the reaction as described under "Experimental Procedures." This phosphorylated enzyme was then incubated at 30°C for varying periods of time in the presence and absence of 14-3-3 proteins. After a 45-min incubation in the presence of 14-3-3 proteins, there was a 6% loss of activity, whereas in the absence of 14-3-3 proteins, there was a 17% loss of activity. These results are the first indication that at least part of the 
FIG. 2.
Effect of varying amounts of 14-3-3 proteins on the activity of TPH. TPH (0.7 g) was phosphorylated by PKA in the presence of varying amounts of 14-3-3 proteins as described under "Experimental Procedures." After phosphorylation, hydroxylase activity was measured (Ⅺ). For unphosphorylated TPH, TPH was incubated with bovine serum albumin (1 g) instead of PKA, and then hydroxylase activity was measured (छ). One unit of TPH is defined as the amount that catalyzes the formation of 1 nmol of 5-HTP/15 min at 37°C.
FIG. 3. Activation of TPH by 14-3-3 proteins.
TPH was phosphorylated as described under "Experimental Procedures," and then hydroxylase activity was measured in the presence (Ⅺ) and absence (छ) of 14-3-3 proteins. Unphosphorylated TPH (E) was treated similarly, but no PKA was added. In all cases, 0.7 g of TPH and 2.2 g of 14-3-3 proteins were used in a 50-l reaction mixture. activation of TPH due to 14-3-3 may be due to a stabilizing effect of 14-3-3. This stabilizing effect of 14-3-3 is similar to the effect of 14-3-3 proteins on human tyrosine hydroxylase phosphorylated by Ca 2ϩ /calmodulin-dependent protein kinase II (44).
14-3-3 Proteins Inhibit the Dephosphorylation of Phosphorylated Tryptophan Hydroxylase-
The previous results suggested that 14-3-3 proteins might stabilize phosphorylated TPH from inactivation by preventing its dephosphorylation. To examine this possibility, we measured the effect of 14-3-3 on the dephosphorylation of 32 P-labeled TPH catalyzed by protein phosphatase-1. Phosphorylated TPH (1 g) was incubated with protein phosphatase-1 in the presence or absence of 14-3-3 proteins (10 g) at 37°C. As shown in Fig. 4, 14-3-3 proteins completely protected the phosphorylated enzyme against phosphatase-catalyzed dephosphorylation. In contrast, ϳ90% dephosphorylation took place in the absence of 14-3-3. This inhibition of TPH dephosphorylation by 14-3-3 does not result from 14-3-3 proteins directly inhibiting protein phosphatase-1 as the dephosphorylation of other proteins by protein phosphatase-1 is not inhibited by 14-3-3 proteins (26, 62) .
Detection of Complex Formation between 14-3-3 and TPH-
We next examined whether 14-3-3 proteins can interact with TPH in a phosphorylation-dependent manner (Fig. 5) . TPH under phosphorylating or nonphosphorylating conditions was immobilized on Ni 2ϩ -NTA resin via its six-histidine tag and incubated with 14-3-3 proteins. In a control experiment, the resin without added TPH was incubated with 14-3-3 proteins. The immobilized enzyme and control resins were washed with equilibration buffer to remove unbound 14-3-3 (lanes 1-3) and then with 150 mM imidazole in 50 mM Tris-Cl, pH 8.5, to elute TPH and any bound 14-3-3 proteins (lanes 4 -6) . No 14-3-3 proteins bound to the control resins (lanes 1 and 4) . 14-3-3 appeared to bind to both unphosphorylated TPH (lane 5) and phosphorylated TPH (lane 6), but much more 14-3-3 bound to phosphorylated TPH than to unphosphorylated TPH. From the scanning of the stained gels, we calculated that 1 mol of phosphorylated TPH monomer bound 0.9 mol of 14-3-3 dimer and that 1 mol of unphosphorylated TPH monomer bound 0.2 mol of 14-3-3 dimer.
Direct Binding of Phosphorylated TPH to 14-3-3-The binding of phosphorylated TPH to 14-3-3 was also examined using SPR spectroscopy. The BIAcore 2000 biosensor (33) uses an optical method to detect changes in the refractive index within a thin dextran matrix. The binding of protein to the matrix alters the refractive index within the matrix, and it is this refractive index change that is detected and quantified in arbitrary resonance units (RU). This method detects binding in real time and allows the rates of association (k on ) and dissociation (k off ) to be determined directly. The 14-3-3 proteins were attached to the sensor surface and tested for their ability to bind phosphorylated TPH. The upper trace in Fig. 6A shows the interaction of phosphorylated TPH with immobilized 14-3-3 proteins. Unphosphorylated TPH (lower trace) gave a much smaller increase in RU. The association rate (k on ) was calculated by the increase in RU observed after TPH injection, and the dissociation rate (k off ) was calculated from the decrease in RU observed after completion of the TPH injection while the sensor surface was washed with buffer. Using the BIAcore curve-fitting program, k on was estimated to be 2 ϫ 10 4 M Ϫ1 s Ϫ1 , and k off was estimated to be 6 ϫ 10 Ϫ4 s Ϫ1 . The equilibrium dissociation constant (K D ) calculated from the ratio k off /k on was 30 nM. No significant change in kinetic constants was observed when the flow rate was varied (2, 5, and 10 l/min). Association and dissociation rate constants were not influenced by a variation in the amount of immobilized 14-3-3. K D for phosphorylated TPH was also calculated from the plot of steady-state resonance (R eq ) versus TPH concentration after correction for nonspecific binding (Fig. 6B) . K D was calculated to be 26 nM. The data shown in Fig. 6B were obtained using less immobilized 14-3-3 proteins than those shown in Fig. 6A . The corresponding Scatchard plot is shown in Fig. 6B (inset) . The apparent K a calculated from the slope of the straight line was estimated to be 4.5 ϫ 10 7 M
Ϫ1
. DISCUSSION The characterization of TPH and its interaction with 14-3-3 proteins have been hampered by low yields of TPH from animal tissues and the inherent instability of TPH expressed in bacteria (10 -12) . In this study, we avoided these problems by using a baculovirus expression system. Rabbit brain fusion TPH was expressed in this system, and the His 6 -tagged enzyme was purified by affinity chromatography on Ni 2ϩ -NTA resin. The purified soluble and active TPH showed a single protein -NTA resin were incubated for 10 min with Buffer F (lanes 1 and 4) or with Buffer F containing 3.5 g of unphosphorylated TPH (lanes 2 and 5) or phosphorylated TPH (lanes 3 and 6) . The 14-3-3 proteins (2.2 g) were then added; and after a 15-min incubation, the resin was washed three times with 100 l of Buffer F, followed by elution with 50 l of 50 mM Tris-Cl, pH 8.5, containing 150 mM imidazole. The first washes with Buffer F (lanes 1-3) and elution with imidazole buffer (lanes 4 -6) were examined by SDS-PAGE and Coomassie Blue staining. Molecular mass markers are shown in lane 7.
band on SDS-PAGE with a calculated molecular mass of ϳ54 kDa (Fig. 1) . Like native rabbit brain TPH (12, 45) , our rabbit brain recombinant histidine-tagged TPH exhibits biphasic kinetics, with strong inhibition by L-tryptophan above 0.2 mM in the presence of (6R)-5,6,7,8-tetrahydrobiopterin (data not shown). It has been observed that in the presence of (6R)-5,6,7,8-tetrahydrobiopterin, lysolecithin-activated phenylalanine hydroxylase (46) and tyrosine hydroxylase (47) also show inhibition by high concentrations of the substrates phenylalanine and tyrosine, respectively. The 14-3-3 proteins increased the V max of phosphorylated TPH without affecting the K m values for (6R)-5,6,7,8-tetrahydrobiopterin and L-tryptophan (data not shown). Similarly, it has been reported that 14-3-3 proteins stimulated the V max of tyrosine hydroxylase phosphorylated by Ca 2ϩ /calmodulin-dependent protein kinase II (48) . Phosphorylation of native tyrosine hydroxylase mediated by PKA causes an activation of the bovine and rat brain enzymes (49 -51) . There are conflicting results on the effect of phosphorylation and 14-3-3 proteins on TPH activity. The activity of partially purified rat brainstem TPH phosphorylated by PKA (43) and by Ca 2ϩ /calmodulin-dependent protein kinase II (52) has been reported to be stimulated both by 14-3-3 proteins and by the recombinant glutathione S-transferase-fused 14-3-3 -isoform (53) . In contrast, TPH purified from rat brainstem has been reported to be phosphorylated by endogenous PKA, but there was no evidence for phosphorylation-mediated activation even in the presence of 14-3-3 proteins (54). Our recombinant TPH expressed in insect cells was phosphorylated by PKA, and 14-3-3 proteins increased its hydroxylase activity ϳ1.5-fold (Fig. 3 ). It appears that activation of TPH is a two-step process: modest activation due to phosphorylation and further activation by 14-3-3 proteins. An additional effect of 14-3-3 binding, probably related to its ability to activate, is to stabilize phosphorylated TPH.
The interaction of phosphorylated TPH with 14-3-3 proteins was examined by SPR spectroscopy and affinity chromatography. The stoichiometry of 0.9 mol of 14-3-3 dimer/mol of phosphorylated TPH monomer calculated from the affinity chromatography data (Fig. 6 ) is higher than the reported value (24) . The source of enzyme used in that study was different, and a pterin column was used to isolate the complex. We detected a low level of 14-3-3 proteins binding to unphosphorylated TPH, 0.2 mol of 14-3-3 dimer/mol of unphosphorylated TPH monomer. This could be due either to the TPH expressed in baculovirus being partially phosphorylated or to a low affinity between unphosphorylated TPH and 14-3-3 proteins. The binding of phosphorylated TPH to immobilized 14-3-3 and its dissociation were easily detected using SPR. We obtained a K D of 30 nM by curve-fitting our sensorgrams, which is in good agreement with the affinity constant (K a ϭ 4.5 ϫ 10 7 M Ϫ1 ) obtained from the Scatchard plot analysis. The value for K D determined with BIAcore is in good agreement with the concentration of 14-3-3 proteins needed to stimulate phosphorylated TPH activity; 40 nM gave half-maximal stimulation. We cannot rule out the possibility of some binding between our unphosphorylated TPH and 14-3-3 proteins as indicated by the small increase in RU values. The data for unphosphorylated TPH did not fit into a simple binding equation.
Kinetic data obtained from SPR sensorgrams have the advantage of working with a label-free system. Changes in protein properties by chemical modification can be avoided by this approach, but SPR measurements have the disadvantage that one of the proteins must be immobilized. This could influence the binding kinetics or disturb the system. For example, when we immobilized histidine-tagged TPH over the Ni 2ϩ -NTA sensor chip, we got very little 14-3-3 binding. However, immobilization of proteins has been successfully performed for many different systems (55, 56) .
The K D values determined by this technique for the binding of 14-3-3 proteins to TPH are similar to those for the binding of glutathione S-transferase/14-3-3 to serine-phosphorylated Raf-1 peptide (57). At present, it is unclear which serine residue in TPH is the site of 14-3-3 binding. Systematic amino acid substitutions in TPH are ongoing in our laboratory, and subsequent analysis by SPR spectroscopy would seem to be a useful strategy to determine biologically significant changes in binding affinity. The putative binding motif for 14-3-3 binding is RSXSXP (57) . Our preliminary data indicate that there are two serine residues in our TPH preparation that can be phosphorylated, serine 58 and serine 260, and that Ser-58 is much more readily phoshorylated by PKA than Ser-260. Ser-58 has also been identified as the site of PKA-mediated phosphorylation (58) . These results suggest that in the experiments in which 14-3-3 proteins protect against the dephosphorylation of phosphorylated TPH, the binding may involve Ser-58 rather than Ser-260. However, the amino acid sequence around Ser-58 does not conform to the RSXSXP motif. We are currently investigating this.
The 14-3-3 family of proteins clearly has important role(s) in mammalian brain, where levels as high as 13.3 g/ml soluble FIG. 6 . A, BIAcore sensorgram of TPH binding to 14-3-3 proteins. The 14-3-3 proteins were immobilized at a concentration of 50 g/ml over the sensor chip as described under "Experimental Procedures." 500 nM phosphorylated (ϩPhosphorylation) or unphosphorylated (ϪPhospho-rylation) TPH was passed over the surface at a flow rate of 5 l/min for 10 min at 25°C. At the end of these injections, equilibration buffer was passed through the flow cell. The decreases in RU result from the dissociation of TPH from the 14-3-3 proteins. B, affinity of the interaction of phosphorylated TPH with 14-3-3 proteins. Steady-state resonance (R eq ) was calculated at each concentration for phosphorylated TPH using BIAevaluation 2.1 software from the binding data after correction for nonspecific binding. Inset, Scatchard plot derived from the data in B for phosphorylated TPH.
protein (ϳ1%) have been measured (42) . However, no physiological function had been attributed to 14-3-3 until it was shown to be identical to an activator protein of tyrosine hydroxylase and TPH (59) . The 14-3-3 proteins contain a mixture of seven different isoforms, share a common immunological determinant, and have highly similar amino acid sequences (60) . The crystal structures of the -and -isoforms were determined (61, 62) and appear to consist of two structural regions that are distinguishable by their different charge characteristics: the almost neutral amino-terminal region and the strongly acidic carboxyl-terminal region. The carboxyl-terminal region of the recombinant 14-3-3 -isoform (amino acids 171-213) has been shown to bind to phosphorylated TPH (53) . The structural features of the two isoforms of 14-3-3 and the domain organization of tyrosine hydroxylase and TPH suggest that the 14-3-3 proteins bind to the regulatory domain of the phosphorylated hydroxylases through their acidic carboxyl-terminal region and activate the hydroxylases by inducing an active conformation. It appears that the binding of 14-3-3 proteins to their target proteins is mediated by phosphorylation. For example, protein phosphatase treatment of Bcr (25) and Raf-1 (26) inhibits their binding to 14-3-3 proteins. The dephosphorylation of histone H1 (63), Raf-1 (57) , and the phosphorylated nitrate reductase from spinach leaves (64) is inhibited by 14-3-3 proteins.
Although the 14-3-3 proteins have been shown to be an important factor for the Ca 2ϩ /calmodulin-dependent protein kinase II-dependent activation of tyrosine hydroxylase and TPH, we are hypothesizing a model (Fig. 7) for the first time for the role of 14-3-3 in the activation and binding of phosphorylated TPH. The binding of 14-3-3 to phosphorylated TPH appears to have two effects. First, it binds to the phosphorylated form of TPH and increases its hydroxylase activity. Second, it prevents TPH dephosphorylation either by changing its conformation or by directly blocking access of the phosphatase to the phosphorylated serine. Because unphosphorylated TPH is less stable than phosphorylated TPH, 14-3-3 proteins binding to phosphorylated TPH in the cell would be expected to stabilize TPH by preventing its dephosphorylation by cellular phosphatase. The regulation of TPH by phosphorylation and binding to 14-3-3 proteins may be a concerted phenomenon. The protection against dephosphorylation may result in an increase in activity and stabilization of the enzyme due to altered conformation.
Further investigation is needed to identify the serine residue(s) in TPH that on phosphorylation interact with 14-3-3 proteins and regulate hydroxylase activity. It is also necessary to elucidate the structural and functional changes that mediate the activation of TPH.
